Waystar Holding Corp. $WAY Shares Sold by Renaissance Technologies LLC

Renaissance Technologies LLC lowered its position in shares of Waystar Holding Corp. (NASDAQ:WAY) by 60.5% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 423,200 shares of the company’s stock after selling 649,100 shares during the quarter. Renaissance Technologies LLC’s holdings in Waystar were worth $10,203,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of WAY. Capricorn Fund Managers Ltd lifted its holdings in shares of Waystar by 46.2% during the 4th quarter. Capricorn Fund Managers Ltd now owns 738,263 shares of the company’s stock valued at $24,178,000 after acquiring an additional 233,141 shares in the last quarter. Renaissance Capital LLC purchased a new position in Waystar in the fourth quarter valued at about $2,273,000. Clarkston Capital Partners LLC purchased a new position in Waystar in the first quarter valued at about $22,917,000. Hsbc Holdings PLC acquired a new position in shares of Waystar during the first quarter worth about $5,625,000. Finally, Advisors Preferred LLC purchased a new stake in shares of Waystar in the fourth quarter worth about $3,975,000.

Waystar Stock Performance

Waystar stock opened at $21.11 on Monday. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.36. The stock has a 50 day moving average of $20.80 and a 200-day moving average of $23.14. The stock has a market cap of $4.05 billion, a P/E ratio of 30.16, a price-to-earnings-growth ratio of 0.82 and a beta of 0.06. Waystar Holding Corp. has a 52 week low of $17.26 and a 52 week high of $41.47.

Waystar (NASDAQ:WAY) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $0.43 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.03. The firm had revenue of $319.67 million for the quarter, compared to the consensus estimate of $316.21 million. Waystar had a net margin of 11.18% and a return on equity of 7.03%. The firm’s revenue was up 18.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.36 EPS. On average, analysts expect that Waystar Holding Corp. will post 1.47 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the company. KeyCorp reiterated an “overweight” rating on shares of Waystar in a research note on Friday. Raymond James Financial restated a “strong-buy” rating and issued a $32.00 price target on shares of Waystar in a report on Thursday, April 30th. Bank of America lowered their price objective on shares of Waystar from $45.00 to $38.00 and set a “buy” rating for the company in a research report on Friday, April 10th. Wells Fargo & Company dropped their price objective on shares of Waystar from $36.00 to $33.00 and set an “overweight” rating on the stock in a research note on Thursday. Finally, UBS Group reduced their target price on shares of Waystar from $37.00 to $33.00 and set a “buy” rating on the stock in a research report on Thursday. Three analysts have rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Waystar currently has an average rating of “Moderate Buy” and an average price target of $35.14.

Waystar Company Profile

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.